5α-Reductase inhibitors, Aanticoagulants, Actigraphy, Adenotonsillectomy, Adolescent, Antegrade ejaculation, Antidiuretic, Antimuscarinics, Apnea, Aquablation, Arousal, Avanafil, Benign Prostatic Diseases, bipolar TURO, Bladder, Bladder capacity, Bladder injury, Bladder outlet obstruction, Bladder trauma, BNC, BOO, BOOI, BPD, BPE, BPH, BPO, Chronic bacterial prostatitis, Circadian rhythms, Clinical practice guidelines, Clinical trial, Corticotropin-releasing factor, CP/CPPS, CPPS, Depression, Desmopressin, Detrusor, Detrusor hypocontractility, Detrusor overactivity, Diagnosis, Dihydrotestosterone, Drug adherence, Drug therapy, Dutasteride, EAU, Ejaculation, Ejaculation preservation, Ejaculatory dysfunction, Endoscopic surgery, Enuresis, Epidemiology, Erectile dysfunction, Fexapotide triflutate, Fibrosis, Finasteride, Fractures, Frequency volume chart, GL-XPS, GreenLight laser, Guidelines, Herbal medicines, HoLEP, Hypogonadism, Hypoxia, Impaired contractility, Incontinence, Infertility, Inflammation, Inflammatory biomarkers, Innervation, IPP, IPSS, iTIND, Laparoscopy, Laser Bipolar, Laser prostatectomy, Laser therapy, LUT, LUTS, Major cardiac adverse event, Management of Non-Neurogenic LUTS incl. BPO, Medical therapy, Melatonin, Meta analysis, Meta regression, Metabolic syndrome, Microbiome, Micturition chart, Minimally invasive surgical therapy, minimally invasive techniques, Mirabegron, Monotherapies, Multiple sclerosis, Muscarinic antagonist, Neuromodulation, nitinol, Nocturia, Nocturia Symposium, Nocturia Think Tank, Nocturnal enuresis, Nocturnal Enuresis and Alarm Treatment, Nocturnal Enuresis and Desmopressin, Nocturnal Enuresis and Quality of Life, Nocturnal polyuria, Nocturnal voiding frequency, Noninvasive, NX-1207, OAB, Obesity, Obstructive sleep apnea, Obstructive sleep apnea syndrome, Overactive bladder, Paediatric Urology, Parental punishment, Pathogenesis, Pathophysiology, Patient satisfaction, Patient-reported outcome, Permixon, Pharmacology, Phenotypically directed multimodal management, Phosphodiesterase type 5 inhibitor, Phosphodiesterase type 5 inhibitors, Phytotherapy, Placebo effect, Plasmakinetic enucleation, Potential risk factors, Prospective study, Prostate, Prostate arterial embolisation, Prostate surgery, Prostate-specific antigen, Prostatectomy, Prostatic, Prostatic arterial embolization, Prostatic artery embolization, Prostatic hyperplasia, Prostatitis, PUL, QoL, Quality of life, Randomized trial, RASP, Remission, Renal function profile, Retrograde ejaculation, Robotic, Robotic surgery, Robotics, Salivary alpha-amylase, Serenoa repens, Sexual Dysfunction, Sexual dysfunctions, Sildenafil, Simple prostatectomy, Sleep quality, Sleep-disordered breathing, Sodium diuresis, Solifenacin, Stem cells, Surgery, Surgical intervention, Sympathetic nervous activity, Systematic review, Tadalafil, Tamsulosin, Telomerase, Testosterone, ThuLEP, TmLRP, Tolterodine, TUR syndrome, TURis, TURP, Ultrasonography, Underactive bladder, urethral implantable device, Urethral injury, Urethral trauma, Urinary Incontinence in Adults, Urinary nerve growth factor, Urinary sphincter, Urodynamic, Urodynamics, Urolift, Vardenafil, Voiding, Voiding diary, Voiding dysfunction, Water diuresis, α-Adrenergic blocker, α-Adrenoceptor antagonists, α-Blocker, α-blockers, α1-Blockers